Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
Salt CompositionZolpidem 12.5mg
You Searched
Zolfresh 12.5mg Tablet CR
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Insomnia
Customers also bought
More About Zolfresh
Benefits
In Treatment of Insomnia Insomnia is a common sleep disorder in which there is difficulty in falling or staying asleep at night. Zolfresh 12.5mg Tablet CR helps treat insomnia as well as improves sleep quality. Zolfresh 12.5mg Tablet CR works by slowing activity in the brain to allow sleep. This helps you relax and feel more energetic. It also helps you concentrate better and improves your quality of life. With Zolfresh 12.5mg Tablet CR, your sleep problems should improve within 7 to 10 days. Apart from this, it is advisable to make some lifestyle changes to sleep better.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Zolfresh 12.5mg Tablet CR is to be taken empty stomach.
How it works
Zolfresh 12.5mg Tablet CR belongs to a group of medicines called non-benzodiazepine hypnotics. It has hypnotic, sedative, and anticonvulsant (manages fits) properties. It works by binding of the GABAA receptor chloride channel macromolecular complex (a chemical messenger) that slows the activity of the nerve cells in the brain and helps fall asleep.
Unsafe: Avoid consuming alcohol with Zolfresh 12.5mg Tablet CR as it is deemed unsafe.
Seek medical advice from your doctor: Zolfresh 12.5mg Tablet CR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Zolfresh 12.5mg Tablet CR is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Not Safe: Zolfresh 12.5mg Tablet CR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Safe when prescribed by an expert: Zolfresh 12.5mg Tablet CR is safe to use in patients with kidney disease. No dose adjustment of Zolfresh 12.5mg Tablet CR is recommended. However, inform your doctor if you have any kidney disease.
Caution Advised: Zolfresh 12.5mg Tablet CR should be used with caution in patients with liver disease. Dose adjustment of Zolfresh 12.5mg Tablet CR may be needed. Doctor consultation is advised. Zolfresh 12.5mg Tablet CR is generally started at a low dose in patients with mild to moderate liver disease and is not recommended in patients with severe liver disease.
What if I forget to take it?
If you forget a dose of Zolfresh 12.5mg Tablet CR , simply continue with your regular schedule and do not take a double dose.
Manufacturer Address
16th Floor, Godrej BKC, Plot ‚ C, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai ‚ 400 051, India
References
Mihic SJ, Harris RA. Hypnotics and Sedatives. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 467-68
Stahl SM, editor. Zolpidem. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 751-54
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1519-20
Drugs.com. Zolpidem (19 Mar. 2019)
Chaves RG, Lamounier JA, et al. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (19 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
